Show simple item record

dc.creatorDal-Ré, Rafaelen
dc.creatorArribas, Carmenen
dc.creatorTorres, Rocíoen
dc.creatorLuque, Isabelen
dc.date.accessioned2016-01-09T00:35:06Zen
dc.date.available2016-01-09T00:35:06Zen
dc.date.created2011-02-12en
dc.date.issued2011-02-12en
dc.identifierdoi:10.1016/j.medcli.2009.11.011en
dc.identifier.bibliographicCitationMedicina clínica 2011 Feb 12; 136(3): 134-6en
dc.identifier.urihttp://hdl.handle.net/10822/1018597en
dc.identifier.urihttp://dx.doi.org/10.1016/j.medcli.2009.11.011en
dc.formatArticleen
dc.languageesen
dc.sourceeweb:337529en
dc.subject.classificationHuman Experimentation Policy Guidelines / Institutional Review Boardsen
dc.subject.classificationInformed Consent or Human Experimentationen
dc.titleConsentimiento informado en ensayos clínicos y subestudios de Farmacogenéticaen
dc.title.alternativeInformed consent in clinical trials and pharmacogenetic substudiesen
dc.title.alternativeenen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885